Skip to main content
. Author manuscript; available in PMC: 2021 Jan 11.
Published in final edited form as: J Biol Chem. 2003 Jun 4;278(35):33501–33518. doi: 10.1074/jbc.M303591200

Table II. Acyl chain compositions of bulk brain lipids.

Fatty acid compositions of the lipid classes analyzed from pooled brain tissue samples depicted in Fig. 7 were determined by Lipomics TrueMass technology. Profiles of the indicated fatty acid species (at left) for the indicated lipid species (at top) are presented in nanomoles of fatty acid/total moles of fatty acid in each lipid class. The data are presented as PITPα+/+ value/PITPα−/− value. Some differences between corresponding PITPα+/+ and PITPα−/− values are indicated in boldfase. Omega fatty acid nomenclature is employed. The t prefix indicates trans-double bond, and the dm prefix indicates plasmalogen-linked fatty acid. SM indicates sphingomyelin. A precise molecular description of each fatty acid species analyzed is provided at www.lipomics.com/Fatty%20Acids/fatty_acid.htm.

Acyl species CE TG DAG FFA SM CL
14:0 5.4/6.0 3.3/0.0 4.1/5.4 4.1/4.2 2.6/3.5 1.9/2.0
14:1n5 0.0/0.0 0.7/1.0 0.0/0.0 0.0/0.0 0.1/0.2 0.0/0.0
15:0 1.0/1.6 1.6/2.8 0.8/1.1 1.3/1.0 0.5/1.1 1.2/1.7
dm16:0 1.7/3.3 0.7/1.3 0.0/0.4 0.0/0.3 0.2/0.3 2.6/3.1
16:0 23.2/21.4 27.2/28.5 28.9/36.0 33.4/33.9 17.1/16.8 16.1/16.9
t16:1n7 0.9/1.8 0.7/1.3 3.1/3.3 5.4/5.5 1.6/2.6 0.5/2.2
16:1n7 9.1/13.2 3.7/5.6 1.3/1.4 1.2/0.9 1.3/1.8 3.3/1.8
dm18:0 0.0/0.0 0.9/0.7 0.0/0.0 0.4/0.7 0.2/0.1 1.8/2.1
dm18:1n9 1.9/2.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.1/0.2
dm18:1n7 0.0/0.0 0.8/1.0 0.0/0.0 0.0/0.0 0.0/0.0 0.2/0.2
18:0 16.4/11.9 15.4/18.8 23.4/27.9 27.4/30.4 28.7/23.2 21.8/18.9
t18:1n9 0.0/0.0 0.0/0.0 0.0/0.4 0.0/0.0 0.3/0.9 0.0/0.0
18:1n9 12.3/11.5 17.3/18.2 15.2/8.7 12.2/10.7 18.4/25.0 6.0/6.0
18:1n7 0.6/0.0 1.5/1.2 1.6/1.0 1.5/1.3 1.7/1.7 2.1/1.5
t18:2n6 0.0/0.0 0.0/0.0 0.2/0.3 0.0/0.1 0.0/0.0 0.0/0.0
18:2n6 7.2/6.8 16.3/8.9 9.1/4.8 6.1/4.2 2.7/3.1 8.4/2.8
18:3n6 0.0/0.6 0.3/0.6 0.3/0.0 0.2/0.0 0.0/0.0 0.0/0.0
18:3n3 0.2/0.0 0.6/0.4 0.8/0.8 0.3/0.4 0.4/0.4 0.4/0.3
18:4n3 0.0/0.3 0.3/0.5 0.0/0.0 0.0/0.0 0.0/0.0 0.2/0.2
20:0 0.4/1.0 0.8/0.4 0.8/0.7 0.9/0.9 0.4/0.3 0.2/0.2
20:1n15 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
20:1n12 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
20:1n9 6.2/5.6 1.1/2.0 0.4/0.0 0.2/0.3 0.5/0.4 0.4/0.2
20:3n9 0.0/0.0 0.0/0.0 0.3/1.4 0.5/0.4 0.1/0.1 0.0/0.1
20:2n6 0.7/0.9 0.8/0.3 0.3/0.5 0.4/0.4 0.1/0.2 16.9/25.2
20:3n6 0.0/0.0 1.0/0.3 0.4/0.0 0.4/0.3 0.6/0.5 0.5/0.4
20:4n6 1.1/0.0 1.4/0.4 7.7/2.8 3.5/1.9 4.5/3.3 4.4/4.1
20:3n3 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.1 0.1/0.0
20:4n3 0.0/0.0 0.3/0.2 0.0/0.0 0.0/0.0 0.0/0.0 0.3/0.3
20:5n3 0.0/0.0 0.3/0.0 0.2/0.0 0.0/0.1 0.0/0.0 0.0/0.1
22:0 1.1/1.8 0.3/0.3 0.0/0.0 0.0/1.1 0.6/0.4 0.1/0.2
22:1n9 9.3/8.6 1.3/0.3 0.0/1.1 0.0/0.4 0.4/0.3 0.3/0.4
22:2n6 0.0/0.3 0.0/0.0 0.0/2.1 0.0/0.2 0.0/0.1 0.7/0.6
22:4n6 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.2/0.2 0.4/0.0
22:5n6 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
22:5n3 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.6/0.4 0.1/0.2
22:6n3 0.0/0.0 0.3/0.3 1.1/0.0 0.0/0.0 15.9/12.4 8.5/7.3
24:0 1.3/1.5 0.8/0.3 0.0/0.0 0.5/0.6 0.2/0.3 0.2/0.4
24:1n9 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.2/0.4 0.2/0.3
24:6n3 0.0/0.0 0.2/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
HHS Vulnerability Disclosure